Condor Capital Management’s Surmodics SRDX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q4
Sell
-6,712
Closed -$208K 175
2017
Q3
$208K Buy
+6,712
New +$183K 0.04% 170
2016
Q4
Sell
-6,712
Closed -$202K 187
2016
Q3
$202K Buy
+6,712
New +$184K 0.05% 172

Other funds holding SRDX

Condor Capital Management's SRDX Position: Q4 2017 in Review

Condor Capital Management sold out of Surmodics (SRDX) in Q4 2017, closing a stake of 6,712 shares — an estimated $208K sold.

Condor Capital Management first reported a position in SRDX in Q3 2016 and held it in 2 quarters. The position peaked at $208K in Q3 2017. 115 funds tracked by Wall St. Rank hold SRDX as of Q4 2017.

  • Condor Capital Management reported no remaining Surmodics position as of Q4 2017 after selling out during the quarter.
  • Condor Capital Management sold 6,712 Surmodics shares in Q4 2017, an estimated $208K.
  • Condor Capital Management first reported a position in Surmodics in Q3 2016 and held it in 2 quarters.
  • Condor Capital Management's Surmodics position peaked at $208K in Q3 2017.
  • 115 funds tracked by Wall St. Rank held Surmodics as of Q4 2017.

Based on Condor Capital Management's 13F filing for Q4 2017, filed 8 Feb 2018.